US firms selling unapproved 'stem cell treatments'

Miami

HUNDREDS of companies across the United States are selling unapproved stem cell treatments directly to patients, raising concerns about safety and scams in a fast-growing industry, researchers said on Thursday.

At least 351 companies across the United States are marketing unapproved stem cell procedures at 570 individual clinics, the researchers' report in the journal Cell Stem Cell found.